- $16.13m
- $9.90m
- $28.51m
Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview
Brief: Bionano Genomics Inc - On February 4, Terminates Sales Agreement With Cowen Effective February 14, 2025
Brief: Bionano Announces Effective Date Of Reverse Stock Split
Brief: Bionano Genomics Preliminary Q4 2024 Revenue Expected To Be $7.9-$8.1 Million
Brief: Bionano Announces Closing Of $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Brief: Bionano Genomics Q3 Revenue USD 6.1 Million Vs. IBES Estimate USD 7.85 Million
Bionano Genomics Inc expected to post a loss of 21 cents a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of 21 cents a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Bionano Announces Closing Of $3 Mln Registered Direct Offering Priced At-The-Market
Brief: Bionano Announces Preliminary 3Q 2024 Revenues And Cash
U.S. RESEARCH ROUNDUP- Alamo Group, Cognizant, Moderna
Bionano Genomics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Bionano Genomics Q2 Revenue USD 7.8 Million
Bionano Genomics Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Bionano Publishes First Multi-Site Study To Analyze Utility Of OGM In Multiple Myeloma
Brief: Bionano Announces Closing Of Up To $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules